Literature DB >> 28434615

Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.

Jennifer H Foss-Feig1, Brendan D Adkinson2, Jie Lisa Ji3, Genevieve Yang3, Vinod H Srihari2, James C McPartland4, John H Krystal5, John D Murray6, Alan Anticevic7.   

Abstract

Recent theoretical accounts have proposed excitation and inhibition (E/I) imbalance as a possible mechanistic, network-level hypothesis underlying neural and behavioral dysfunction across neurodevelopmental disorders, particularly autism spectrum disorder (ASD) and schizophrenia (SCZ). These two disorders share some overlap in their clinical presentation as well as convergence in their underlying genes and neurobiology. However, there are also clear points of dissociation in terms of phenotypes and putatively affected neural circuitry. We highlight emerging work from the clinical neuroscience literature examining neural correlates of E/I imbalance across children and adults with ASD and adults with both chronic and early-course SCZ. We discuss findings from diverse neuroimaging studies across distinct modalities, conducted with electroencephalography, magnetoencephalography, proton magnetic resonance spectroscopy, and functional magnetic resonance imaging, including effects observed both during task and at rest. Throughout this review, we discuss points of convergence and divergence in the ASD and SCZ literature, with a focus on disruptions in neural E/I balance. We also consider these findings in relation to predictions generated by theoretical neuroscience, particularly computational models predicting E/I imbalance across disorders. Finally, we discuss how human noninvasive neuroimaging can benefit from pharmacological challenge studies to reveal mechanisms in ASD and SCZ. Collectively, we attempt to shed light on shared and divergent neuroimaging effects across disorders with the goal of informing future research examining the mechanisms underlying the E/I imbalance hypothesis across neurodevelopmental disorders. We posit that such translational efforts are vital to facilitate development of neurobiologically informed treatment strategies across neuropsychiatric conditions.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism; Computational modeling; E/I balance; Mechanism; Neuroimaging; Review; Schizophrenia

Mesh:

Year:  2017        PMID: 28434615      PMCID: PMC5436134          DOI: 10.1016/j.biopsych.2017.03.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  171 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

2.  Development of the 40Hz steady state auditory evoked magnetic field from ages 5 to 52.

Authors:  Donald C Rojas; Keeran Maharajh; Peter D Teale; Michelle Ramos Kleman; Tara L Benkers; Jon P Carlson; Martin L Reite
Journal:  Clin Neurophysiol       Date:  2005-11-28       Impact factor: 3.708

3.  Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition.

Authors:  Bilal Haider; Alvaro Duque; Andrea R Hasenstaub; David A McCormick
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

4.  Autistic disorder and schizophrenia: diagnostic overlaps.

Authors:  M M Konstantareas; T Hewitt
Journal:  J Autism Dev Disord       Date:  2001-02

5.  Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory.

Authors:  S G Rao; G V Williams; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 6.  Glutamate and schizophrenia: beyond the dopamine hypothesis.

Authors:  Joseph T Coyle
Journal:  Cell Mol Neurobiol       Date:  2006-06-14       Impact factor: 5.046

7.  High rates of schizophrenia in adults with velo-cardio-facial syndrome.

Authors:  K C Murphy; L A Jones; M J Owen
Journal:  Arch Gen Psychiatry       Date:  1999-10

8.  The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms.

Authors:  Jacob A S Vorstman; Monique E J Morcus; Sasja N Duijff; Petra W J Klaassen; Josien A Heineman-de Boer; Frits A Beemer; Hanna Swaab; René S Kahn; Herman van Engeland
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-09       Impact factor: 8.829

9.  Evoked gamma band synchronization and the liability for schizophrenia.

Authors:  L Elliot Hong; Ann Summerfelt; Robert McMahon; Helene Adami; Grace Francis; Amie Elliott; Robert W Buchanan; Gunvant K Thaker
Journal:  Schizophr Res       Date:  2004-10-01       Impact factor: 4.939

Review 10.  Model of autism: increased ratio of excitation/inhibition in key neural systems.

Authors:  J L R Rubenstein; M M Merzenich
Journal:  Genes Brain Behav       Date:  2003-10       Impact factor: 3.449

View more
  81 in total

1.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

2.  Reduced Local and Increased Long-Range Functional Connectivity of the Thalamus in Autism Spectrum Disorder.

Authors:  Dardo Tomasi; Nora D Volkow
Journal:  Cereb Cortex       Date:  2019-02-01       Impact factor: 5.357

3.  Differential Altered Auditory Event-Related Potential Responses in Young Boys on the Autism Spectrum With and Without Disproportionate Megalencephaly.

Authors:  Rosanna De Meo-Monteil; Christine Wu Nordahl; David G Amaral; Sally J Rogers; Sevan K Harootonian; Joshua Martin; Susan M Rivera; Clifford D Saron
Journal:  Autism Res       Date:  2019-06-03       Impact factor: 5.216

4.  Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution.

Authors:  Samuel J Dienel; John F Enwright; Gil D Hoftman; David A Lewis
Journal:  Schizophr Res       Date:  2019-07-08       Impact factor: 4.939

Review 5.  NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening.

Authors:  Aaron Katzman; Cristina M Alberini
Journal:  Curr Opin Neurobiol       Date:  2017-12-23       Impact factor: 6.627

6.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

7.  Convergent microstructural brain changes across genetic models of autism spectrum disorder-A pilot study.

Authors:  Paul A Rowley; Jose Guerrero-Gonzalez; Andrew L Alexander; John-Paul J Yu
Journal:  Psychiatry Res Neuroimaging       Date:  2018-12-08       Impact factor: 2.376

Review 8.  Thyroid disrupting chemicals and developmental neurotoxicity - New tools and approaches to evaluate hormone action.

Authors:  Katherine L O'Shaughnessy; Mary E Gilbert
Journal:  Mol Cell Endocrinol       Date:  2019-11-21       Impact factor: 4.102

Review 9.  Disrupted circuits in mouse models of autism spectrum disorder and intellectual disability.

Authors:  Carla Em Golden; Joseph D Buxbaum; Silvia De Rubeis
Journal:  Curr Opin Neurobiol       Date:  2017-12-07       Impact factor: 6.627

10.  Convergent brain microstructure across multiple genetic models of schizophrenia and autism spectrum disorder: A feasibility study.

Authors:  Brian R Barnett; Cameron P Casey; Maribel Torres-Velázquez; Paul A Rowley; John-Paul J Yu
Journal:  Magn Reson Imaging       Date:  2020-04-13       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.